Martínez E, Tejada D, Rivas E, Arenas R

Language: Spanish
References: 17
Page: 243-246
PDF size: 101.68 Kb.

ABSTRACT

Background: Onychomycosis in children are related to risk factors such as wearing rubber shoes and/or diseases like Down syndrome, leukemia and cerebral hypoxia.
Objetives: To determine the frequency of onychomycosis in children and adolecents, diagnosed by KOH and/or positive culture in Guatemala City.
Material and Methods: This is a retrospective study in 325 children and adolescents diagnosed with superficial mycosis. Onychomycosis was diagnosed in 94 (24%) cases at the “Instituto de Dermatología y Cirugía de Piel “Prof. Dr. Fernando A. Cordero C.”, in Gua tema la City from May 2008 to April 2009. In all cases KOH and culture were performed.
Resultados: During a year period, 94 patients younger than 18 years of age were studied with clinical diagnosis of onychomycosis. It was confirmed in 78 (82.98%). We observed a slight predominance of females 55% (n = 43). Subungueal distal and lateral onychomycosis was present in 51% (n = 40) and total dystrophic onychomycosis in 28% (n = 22) —in 94% (n = 73) with hyphae, spores or yeast in the KOH. Cultures were positives in 47% (n = 37), and dermatophytes were the most frequent etilogical agents (92% n = 34).
Conclusion: In our population younger than 18 years of age 24% of cases with superficial mycosis had onychomycoses, both genders were equally affected and the main etiological agents were dermatophytes. After this experience the gold standard for diagnosis is the KOH.

REFERENCES

1. Gupta A, Chang P, Del Rosso J. “Onychomycosis in children: Prevalence and management”. Ped Dermatol 1998; 15(6): 464-471.

2. Bonifaz A. Micología médica básica. 2a. ed. México. Méndez-Cervantes. 2000; 60-61.

3. Wolff K, Goldsmith L, Katz S. Fitzpatrick’s Dermatology in General Medicine. 7a. ed. EUA. McGraw-Hill. 2008; (2): 1817.

4. Ginter-Hanselmayer G, Weger W, Smolle J. “Onychomycosis: A new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients”. J Eur Aca Dermatol Ven 2007; 22: 470-475.

5. Gupta A, Skinner A. “Onychomycosis in children: A brief overview with treatment strategies”. Ped Dermatol 2004; 21(1): 74-79.

6. Arenas R, Ruiz-Esmenjaud J. “Onychomycosis in childhood: A current perspective with emphasis on the review of treatment”. Ans Bras Dermatol 2004; 79: 225-232.

7. Sais G, Jucgla A, Peyri J. “Prevalence of dermatophyte onychomycosis in Spain: A cross-septional study”. Br J Dermatol 1995; 132: 758-761.

8. Roberts DT. “Prevalence of dermatophyte in the United Kingdom: Results of an omnibus survey”. Br J Dermatol 1992; 126(39): 23-27.

9. Heikkila H, Stubb S. “The prevalence of onychomycosis in Finland”. Br J Dermatol 1995; 133: 699-703.

10. Romano C, Papini M, Ghilardi A. “Onychomycosis in children: A survey of 46 cases”. Mycoses 2005; 48(6): 430-437.

11. Vásquez del Mercado E, Arenas R. “Onicomicosis en niños. Estudio retrospectivo de 233 casos mexicanos”. Gac Med Mex 2008; 144(1): 7-10.

12. Balleste R, Mosques N, Gezuele E. “Onicomicosis. Revisión del tema”. Rev Med Uruguay 2003; 19: 93-106.

13. Bonifaz A, Saúl A, Mena C, Valencia A. “Dermatophyte onychomycosis in children under 2 years of age: Experience of 16 cases”. J Eur Aca Dermatol Ven 2006; 21(1): 115-117.

14. Piraccini B, Patrizi A, Sisti A. “Onychomycosis in children”. Ex Rev Dermatol 2009; 4(2): 177-184.

15. Lange M, Roszkiewicz J, Szczerkowska-Bobosz A, Jasiel-Walikowska E. “Onychomycosis is no longer a rare finding in children”. Mycoses 2006; 49: 55-59.

16. Vijaya D, Anandkumar H, Geetha A. “Study of onychomycosis”. Indian J Dermatol Leprol 2004; 70(3): 185-186.

17. Sierra V. “Micosis ungueales (I). Onicomicosis por dermatofitos”. Actual Dermatol 1996; 35: 889-896.